A Prospective Epidemiological Study of Acute Mountain Sickness in Nepalese Pilgrims Ascending to High Altitude (4380 m)

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  MacInnis, Martin J ^a   Carter, Eric A ^a   Freeman, Michael G ^b   Pandit, Bidur Prasad ^c   Siwakoti, Ashmita ^c   Subedi, Ankita ^c   Timalsina, Utsav ^c   Widmer, Nadia ^a   Thapa, Ghan Bahadur ^c   Koehle, Michael S ^a   Rupert, Jim L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c TRIBHUVAN UNIVERSITY   (Nepal)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ACUTE MOUNTAIN SICKNESS; ADULT; ALTITUDE DISEASE; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; EPIDEMIOLOGICAL DATA; ETHNIC GROUP; FEMALE; FOLLOW UP; GARLIC; HUMAN; INFORMATION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEPAL; NEPALESE; PROPHYLAXIS; PROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SYMPTOM;

ADULT; ALTITUDE; ALTITUDE SICKNESS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEPAL; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84885105892     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075644     Document Type: Article

References (34)

1. Roach RC, Bärtsch P, Oelz O, Hackett P (1993) Lake Louise AMS Scoring Consensus Committee: The Lake Louise acute mountain sickness scoring system. In: Sutton JR, Houston C, Coates G, editors. Hypoxia and molecular medicine. Burlington, VT: Queen City Printers. 272-274.
2. Imray C, Booth A, Wright A, Bradwell A, (2011) Acute altitude illnesses. BMJ 343: d4943-d4943.
3. Hackett PH, Roach RC, (2001) High-altitude illness. N Engl J Med 345: 107-114.
4. Wilson MH, Newman S, Imray CH, (2009) The cerebral effects of ascent to high altitudes. The Lancet Neurol 8: 175-191.
5. MacInnis MJ, Wang P, Koehle MS, Rupert JL, (2011) The genetics of altitude tolerance: the evidence for inherited susceptibility to acute mountain sickness. J Occup Environ Med 53: 159-168.
6. Luks AM, McIntosh SE, Grissom CK, Auerbach PS, Rodway GW, et al. (2010) Wilderness Medical Society Consensus Guidelines for the Prevention and Treatment of Acute Altitude Illness. Wilderness and Environ Med 21: 146-155.
7. Richalet JP, Larmignat P, Poitrine E, Letournel M, Canoui-Poitrine F, (2012) Physiological Risk Factors of Severe High Altitude Illness: A Prospective Cohort Study. Am J Respir Crit Care Med 185 192: 198.
8. Wang S-H, Chen Y-C, Kao W-F, Lin Y-J, Chen J-C, et al. (2010) Epidemiology of acute mountain sickness on Jade Mountain, Taiwan: an annual prospective observational study. High Alt Med Biol 11: 43-49.
9. Kayser B, (1991) Acute mountain sickness in western tourists around the Thorong pass (5400 m) in Nepal. J Wilderness Med 2: 110-117.
10. Hackett PH, Rennie D, Levine HD, (1976) The incidence, importance, and prophylaxis of acute mountain sickness. Lancet 2: 1149-1155.
11. Maggiorini M, Bühler B, Walter M, Oelz O, (1990) Prevalence of acute mountain sickness in the Swiss Alps. BMJ 301: 853-855.
12. Mairer K, Wille M, Burtscher M, (2010) The prevalence of and risk factors for acute mountain sickness in the Eastern and Western Alps. High Alt Med Biol 11: 343-348.
13. Li X, Tao F, Pei T, You H, Liu Y, et al. (2011) Population level determinants of acute mountain sickness among young men: a retrospective study. BMC Public Health 11: 740.
14. Wu T, Ding S, Liu J, Jia J, Chai Z, et al. (2012) Who are more at risk for acute mountain sickness: a prospective study in Qinghai-Tibet railroad construction workers on Mt. Tanggula. Chin Med J 125: 1393-1400.
15. Basnyat B, (1993) Acute mountain sickness in local pilgrims to a high altitude lake (4154 m) in Nepal. J of Wilderness Med 4: 286-292.
16. Basnyat B, Subedi D, Sleggs J, Lemaster J, Bhasyal G, et al. (2000) Disoriented and ataxic pilgrims: an epidemiological study of acute mountain sickness and high-altitude cerebral edema at a sacred lake at 4300 m in the Nepal Himalayas. Wilderness Environ Med 11: 89-93.
17. Basnyat B, Lemaster J, Litch JA, (1999) Everest or bust: a cross sectional, epidemiological study of acute mountain sickness at 4243 meters in the Himalayas. Aviat Space Environ Med 70: 867-873.
18. Eichenberger U, Weiss E, Riemann D, Oelz O, Bärtsch P, (1996) Nocturnal periodic breathing and the development of acute high altitude illness. Am J Respir Crit Care Med 154: 1748-1754.
19. Nussbaumer-Ochsner Y, Ursprung J, Siebenmann C, Maggiorini M, Bloch KE, (2012) Effect of short-term acclimatization to high altitude on sleep and nocturnal breathing. Sleep 35: 419-423.
20. Nussbaumer-Ochsner Y, Schuepfer N, Siebenmann C, Maggiorini M, Bloch KE, (2011) High Altitude Sleep Disturbances Monitored by Actigraphy and Polysomnography. High Alt Med Biol 12: 229-236.
21. Honigman B, Theis MK, Koziol-McLain J, Roach R, Yip R, et al. (1993) Acute mountain sickness in a general tourist population at moderate altitudes. Ann Intern Med 118: 587-592.
22. Schneider M, Bernasch D, Weymann J, Holle R, Bartsch P, (2002) Acute mountain sickness: influence of susceptibility, preexposure, and ascent rate. Med Sci Sports Exerc 34: 1886-1891.
23. Gaillard S, Dellasanta P, Loutan L, Kayser B, (2004) Awareness, prevalence, medication use, and risk factors of acute mountain sickness in tourists trekking around the Annapurnas in Nepal: A 12-year follow-up. High Alt Med Biol 5: 410-419.
24. Litch JA, (1996) Drug-induced hypoglycemia presenting as acute mountain sickness, after mistaking acetohexamide for acetazolamide. Wilderness and Environ Med 7: 232-235.
25. West JB, (2009) Who should not go high? High Alt Med Biol 10: 1-2.
26. Baumgartner RW, Siegel AM, Hackett PH, (2007) Going High with Preexisting Neurological Conditions. High Alt Med Biol 8: 108-116.
27. You H, Li X, Pei T, Huang Q, Liu F, et al. (2012) Predictive value of basal exhaled nitric oxide and carbon monoxide for acute mountain sickness. Wilderness and Environ Med 23: 316-324.
28. Wu TY, Ding SQ, Liu JL, Jia JH, Chai ZC, et al. (2012) Smoking, acute mountain sickness and altitude acclimatisation: a cohort study. Thorax 67: 914-919.
29. Gertsch JH, Corbett B, Holck PS, Mulcahy A, Watts M, et al. (2012) Altitude Sickness in Climbers and Efficacy of NSAIDs Trial (ASCENT): Randomized, controlled trial of ibuprofen versus placebo for prevention of altitude illness. Wilderness and Environ Med 23: 307-315.
30. Gertsch JH, Lipman GS, Holck PS, Merritt A, Mulcahy A, et al. (2010) Prospective, double-blind, randomized, placebo-controlled comparison of acetazolamide versus ibuprofen for prophylaxis against high altitude headache: the Headache Evaluation at Altitude Trial (HEAT). Wilderness Environ Med 21: 236-243.
31. Kayser B, Dumont L, Lysakowski C, Combescure C, Haller G, et al. (2012) Reappraisal of acetazolamide for the prevention of acute mountain sickness: a systematic review and meta-analysis. High Alt Med Biol 13: 82-92.
32. Morris DM, Beloni RK, Wheeler HE, (2013) Effects of garlic consumption on physiological variables and performance during exercise in hypoxia. Appl Physiol Nutr Metab 38: 363-367.
33. Windsor JS, (2012) Pulse Oximetry and Predicting Acute Mountain Sickness: Are We Asking the Right Questions? Wilderness Environ Med 23: 112-113.
34. Koehle MS, Guenette JA, Warburton DER, (2010) Oximetry, heart rate variability, and the diagnosis of mild-to-moderate acute mountain sickness. Eur J Emerg Med 17: 119-122.